ORATIL-100
ORATIL-100
Authorised
- Tylosin tartrate
Product identification
Medicine name:
ORATIL-100
Active substance:
- Tylosin tartrate
Target species:
-
Chicken (hen)
-
Turkey
-
Pig
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Tylosin tartrate108.18/gram(s)100.00gram(s)
Pharmaceutical form:
-
Oral powder
Withdrawal period by route of administration:
-
In drinking water use
-
Chicken (hen)
-
Meat and offal2dayНе се разрешава употребата при птици, които произвеждат или са предназначени да произвеждат яйца за консумация от хора.
-
-
Turkey
-
Meat and offal2dayНе се разрешава употребата при птици, които произвеждат или са предназначени да произвеждат яйца за консумация от хора.
-
-
Pig
-
Meat and offal2day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Farma Sis OOD
Marketing authorisation date:
Manufacturing sites for batch release:
- S P Veterinaria S.A.
- Cenavisa S.L.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-2336
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 29/04/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 29/04/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 29/04/2025